Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$643K Buy
11,642
+717
+7% +$38.9K 0.02% 413
2025
Q4
$536K Sell
10,925
-16,940
-61% -$790K 0.02% 417
2025
Q3
$1.2M Buy
27,865
+9,457
+51% +$369K 0.04% 262
2025
Q2
$707K Buy
18,408
+1,530
+9% +$58.5K 0.03% 329
2025
Q1
$654K Buy
16,878
+2,643
+19% +$96.8K 0.03% 372
2024
Q4
$481K Sell
14,235
-31
-0.2% -$1.12K 0.02% 477
2024
Q3
$583K Buy
14,266
+2,285
+19% +$93.5K 0.02% 436
2024
Q2
$461K Buy
11,981
+1,347
+13% +$56.7K 0.02% 454
2024
Q1
$456K Buy
10,634
+1,088
+11% +$44.9K 0.02% 464
2023
Q4
$354K Buy
+9,546
New +$343K 0.03% 386

Other funds holding GSK

GeoWealth Management's GSK Position: Q1 2026 in Review

GeoWealth Management increased its GSK (GSK) stake by 6.6% in Q1 2026, buying an estimated $38.9K and bringing the position to 11,642 shares worth $643K. The position accounts for 0.02% of the portfolio, ranked #413.

GeoWealth Management first reported a position in GSK in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.2M in Q3 2025. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • GeoWealth Management held 11,642 shares of GSK worth $643K as of Q1 2026.
  • GeoWealth Management bought 717 GSK shares in Q1 2026, an estimated $38.9K.
  • GSK made up 0.02% of GeoWealth Management's portfolio in Q1 2026, its #413 holding.
  • GeoWealth Management first reported a position in GSK in Q4 2023 and has held it in 10 quarters since.
  • GeoWealth Management's GSK position peaked at $1.2M in Q3 2025.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on GeoWealth Management's 13F filing for Q1 2026, filed 13 May 2026.